98%
921
2 minutes
20
Objectives: The aim of this study was to develop a refined method for harmonizing longitudinal cognitive data across several large-scale studies in people with HIV (PWH), in whom cognitive complications are common and heterogeneous in presentation.
Study Design And Setting: We developed a refined method for harmonizing longitudinal cognitive data across five large-scale studies in PWH that used different cognitive batteries with only some overlapping tests-Women's Interagency HIV Study (WIHS), Multicenter AIDS Cohort Study, CNS HIV Antiretroviral Therapy Effects Research (CHARTER), National NeuroAIDS Tissue Consortium, and the HIV Neurobehavioral Research Program. Traditional data harmonization methods using latent variable models focus on cross-sectional data and require the presence of common cognitive tests to serve as "linking" assessments. However, the absence of such common tests for certain cognitive domains can preclude the direct application of these traditional techniques. To address these challenges, we developed a harmonization method that leveraged a second-order factor model, which capitalized on the structural relationships among cognitive domains.
Results: Our approach yielded harmonized cognitive domain scores that are demographically consistent across different cohorts and exhibit strong correlations with the raw or log transformed (eg, timed outcomes) cognitive test scores. These harmonized scores accurately reflected variations according to age, educational status, and other demographic factors, while preserving participants' longitudinal cognitive trajectories.
Conclusion: Our harmonization methods are essential for future analyses of large-scale, retrospective data to understand the heterogeneity in cognitive complications in PWH. These methods can be applied to harmonize new datasets with similar measures.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781957 | PMC |
http://dx.doi.org/10.1016/j.jclinepi.2024.111620 | DOI Listing |
Alzheimers Dement
September 2025
Department of Neurology, Beijing TianTan Hospital, Capital Medical University, Beijing, China.
Cognitive impairment and dementia, including Alzheimer's disease (AD), pose a global health crisis, necessitating non-invasive biomarkers for early detection. This review highlights the retina, an accessible extension of the central nervous system (CNS), as a window to cerebral pathology through structural, functional, and molecular alterations. By synthesizing interdisciplinary evidence, we identify retinal biomarkers as promising tools for early diagnosis and risk stratification.
View Article and Find Full Text PDFAlzheimers Dement
September 2025
Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea.
Introduction: We developed and validated age-related amyloid beta (Aβ) positron emission tomography (PET) trajectories using a statistical model in cognitively unimpaired (CU) individuals.
Methods: We analyzed 849 CU Korean and 521 CU non-Hispanic White (NHW) participants after propensity score matching. Aβ PET trajectories were modeled using the generalized additive model for location, scale, and shape (GAMLSS) based on baseline data and validated with longitudinal data.
Alzheimers Dement (Amst)
September 2025
Introduction: Simple screening tools are critical for assessing Alzheimer's disease (AD)-related pre-dementia changes. This study investigated longitudinal scores from the Quick Dementia Rating System (QDRS), a brief study partner-reported measure, in relation to baseline levels of the AD biomarker plasma pTau217 in individuals unimpaired at baseline.
Methods: Data from the Wisconsin Registry for Alzheimer's Prevention (N = 639) were used to examine whether baseline plasma pTau217 (ALZpath assay on Quanterix platform) modified QDRS or Preclinical Alzheimer's Cognitive Composite (PACC3) trajectories (mixed-effects models; time = age).
Front Psychol
August 2025
Department of Neurology, Medical University of Graz, Graz, Austria.
Background: Cognitive impairment and psychological complaints are among the most common consequences for patients suffering from Post-Covid-19 condition (PCC). As there are limited training options available, this study examined a longitudinal tablet-based training program addressing cognitive and psychological symptoms.
Methods: Forty individuals aged between 36 and 71 years ( = 49.
Sage Open Aging
September 2025
Texas A&M University, College Station, USA.
Objectives: This study investigated the longitudinal relationship between participation in Cognitively Stimulating Leisure Activities (CSLAs) and the risk of Alzheimer's Disease and Related Dementias (ADRD) in two different groups of older adults with and without Mild Cognitive Impairment (MCI).
Methods: We analyzed data from the Health and Retirement Study, a nationally representative survey of adults in the United States from 2012 to 2020 (MCI = 14,280; without MCI = 13,695) using a Generalized Estimated Equation. The Telephone Interview for Cognitive Status-27 was used to identify samples with MCI, with scores ranging from 7 to 11.